-
平臺編號：bio-49364
-
國際編號：ATCC PCS-200-010
-
細胞信息： Primary Epidermal Keratinocytes
-
規(guī)格：frozen
-
用途：ATCC原裝進口
-
服務費用：
加載中…… - 訂購
-
注意事項：僅用于科學研究或者工業(yè)應用等非醫(yī)療目的不可用于人類或動物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫為準）
Primary Epidermal Keratinocytes
ATCC? Number:PCS-200-010
Name: Primary Epidermal Keratinocytes; Normal, Human, Neonatal
Biosafety Level:1
Shipped: frozen
Organism: Homo sapiens (human)
Growth Properties: Adherent
Age: Neonatal
Morphology: Cobblestone appearance; cells are rounded, not flat
Number of Viable Cells per Vial: ≥ 500,000 in cryopreservation medium
Volume per Vial: 1 ml
Gender: Male
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Related Products:Primary Epidermal Keratinocytes; Normal, Human, Adult (ATCCPCS-200-011)
Dermal Cell Basal Medium (ATCCPCS-200-030)
Keratinocyte Growth Kit (ATCCPCS-200-040)
Dulbecco's Phosphate Buffered Saline (D-PBS) (ATCC30-2200)
Trypsin-EDTA for Primary Cells (ATCCPCS-999-003)
Trypsin Neutralizing Solution (ATCCPCS-999-004)
Gentamicin-Amphotericin B Solution (ATCCPCS-999-025)
Penicillin-Streptomycin-Amphotericin B Solution (ATCCPCS-999-002)
Phenol Red (ATCCPCS-999-001)
Comments:A complete solution to propagate neonatal keratinocytes. The serum-free media is formulated to inhibit fibroblast growth, and the low calcium concentration (60 μM) slows differentiation. No feeder layers, extracellular matrix proteins or other substrates are required.
Applications:Toxicology, wound repair, skin cancer, response to UV radiation, psoriasis, eczema, viral infection, gene delivery systems, cellular differentiation
Viability:≥ 50%
Population Doubling Capacity:≥ 15 in complete growth medium
Sterility Tests:Bacteria and Yeast: Negative Mycoplasma: Negative
Testing:Hepatitis B: Negative Hepatitis C: Negative HIV: Negative
Name: Primary Epidermal Keratinocytes; Normal, Human, Neonatal
Biosafety Level:1
Shipped: frozen
Organism: Homo sapiens (human)
Growth Properties: Adherent
Age: Neonatal
Morphology: Cobblestone appearance; cells are rounded, not flat
Number of Viable Cells per Vial: ≥ 500,000 in cryopreservation medium
Volume per Vial: 1 ml
Gender: Male
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Related Products:Primary Epidermal Keratinocytes; Normal, Human, Adult (ATCCPCS-200-011)
Dermal Cell Basal Medium (ATCCPCS-200-030)
Keratinocyte Growth Kit (ATCCPCS-200-040)
Dulbecco's Phosphate Buffered Saline (D-PBS) (ATCC30-2200)
Trypsin-EDTA for Primary Cells (ATCCPCS-999-003)
Trypsin Neutralizing Solution (ATCCPCS-999-004)
Gentamicin-Amphotericin B Solution (ATCCPCS-999-025)
Penicillin-Streptomycin-Amphotericin B Solution (ATCCPCS-999-002)
Phenol Red (ATCCPCS-999-001)
Comments:A complete solution to propagate neonatal keratinocytes. The serum-free media is formulated to inhibit fibroblast growth, and the low calcium concentration (60 μM) slows differentiation. No feeder layers, extracellular matrix proteins or other substrates are required.
Applications:Toxicology, wound repair, skin cancer, response to UV radiation, psoriasis, eczema, viral infection, gene delivery systems, cellular differentiation
Viability:≥ 50%
Population Doubling Capacity:≥ 15 in complete growth medium
Sterility Tests:Bacteria and Yeast: Negative Mycoplasma: Negative
Testing:Hepatitis B: Negative Hepatitis C: Negative HIV: Negative
